30 Participants Needed

Motivational Refinements for Decreasing Destructive Behavior

Recruiting at 1 trial location
BD
DR
Overseen ByDaniel R Mitteer, Ph.D.
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Rutgers, The State University of New Jersey
Must be taking: Psychoactive drugs
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to find better ways to reduce destructive behavior in children with developmental disabilities, such as autism. The study tests new methods to enhance an established treatment called functional communication training (FCT), which helps children communicate their needs instead of acting out. Participants will try different strategies, including PIA-Informed Schedule Thinning, to determine which best maintains positive behavior over time. Children who frequently display destructive behavior, such as aggression, and have not responded to previous treatments might be suitable for this trial. As an unphased trial, this study offers participants a unique opportunity to explore innovative strategies that could significantly improve their quality of life.

Will I have to stop taking my current medications?

The trial requires that participants be on a stable psychoactive drug regimen for at least 10 half-lives per drug or be drug-free. This means you may need to maintain your current medications without changes during the trial.

What prior data suggests that these methods are safe for decreasing destructive behavior?

Previous studies have shown that a method called PIA-Informed Schedule Thinning effectively reduces problem behavior. These studies found that problem behavior remained low when combined with other activities or rewards, suggesting that the treatment is well-tolerated and can effectively manage destructive behavior.

Similarly, using PIA-Informed Schedule Thinning with additional activities or rewards has shown promising results. Research indicates that offering alternative activities or rewards successfully keeps problem behaviors low. For example, providing an alternative activity or reward during treatment helps maintain low levels of destructive behavior.

Overall, both treatments appear safe and well-tolerated, with evidence showing significant reductions in harmful behaviors. This makes them promising options for managing destructive behavior in children with developmental disabilities.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores new methods for reducing destructive behavior through schedule thinning techniques informed by progressive-interval assessments (PIA). Unlike traditional approaches, these methods tailor the starting points for reinforcement schedule thinning based on individual assessments, potentially making them more effective and efficient. Additionally, the use of competing stimuli, like providing alternative activities or rewards, offers a novel way to enhance the impact of these techniques by keeping individuals engaged and reducing the chance of destructive behavior resurgence. This trial aims to find out if these personalized and innovative approaches can lead to more durable improvements in behavior and communication.

What evidence suggests that this trial's treatments could be effective for decreasing destructive behavior?

Research has shown that Functional Communication Training (FCT) helps reduce harmful behavior by teaching children to express their needs more effectively. However, FCT sometimes struggles to maintain these improvements over time. In this trial, one arm will evaluate PIA-Informed Schedule Thinning, which changes how often rewards are given and has reduced problem behavior by 80% in studies. Another arm will assess the addition of competing activities, which can help maintain low levels of harmful behavior by providing engaging alternatives. Together, these methods aim to enhance FCT's effectiveness and longevity by balancing the reinforcement of good behavior and preventing the return of old habits.13467

Who Is on the Research Team?

BD

Brian D Greer, Ph.D.

Principal Investigator

Rutgers, The State University of New Jersey

Are You a Good Fit for This Trial?

This trial is for boys and girls aged 3-17 with developmental disabilities who exhibit destructive behaviors reinforced by social consequences, occurring at least 10 times a day. They must be on a stable drug regimen or drug-free, with no changes in educational placement expected during the study.

Inclusion Criteria

Stable educational plan and placement with no anticipated changes during the child's treatment
I've been on the same mental health medication for a while or not taking any.
Destructive behavior that occurs at least 10 times a day, despite previous treatment
See 3 more

Exclusion Criteria

A comorbid health condition or major mental disorder that would interfere with study participation
My protective supports and medication for self-injury are stable.
Occurrence of self-injury during study assessments that presents a risk of serious or permanent harm (e.g., detached retinas) based on routine clinical-risk assessment
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo reinforcement schedule thinning using functional communication training (FCT) with progressive interval assessment (PIA) and competing stimuli

4 weeks
Multiple sessions per week

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • PIA-Informed Schedule Thinning
  • PIA-Informed Schedule Thinning with Competing Stimuli
  • Traditional Schedule Thinning
Trial Overview The trial tests two enhancements to Functional Communication Training (FCT) aimed at reducing destructive behavior: one speeds up reinforcement schedule thinning using progressive interval assessment; another adds competing stimuli to prevent relapse.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: Evaluation of PIA-Informed Schedule ThinningExperimental Treatment2 Interventions
Group II: Evaluation of Competing ItemsExperimental Treatment2 Interventions
Group III: Effects of Competing Items on PIA OutcomesExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials
471
Recruited
81,700+

Published Research Related to This Trial

In a study involving college students, both methods of thinning reinforcement—differential reinforcement of alternative behavior and differential reinforcement of other behavior—showed tolerance to problem behavior, indicating that both methods can be effective in reducing undesired actions.
However, the differential reinforcement of alternative behavior led to higher rates of contextually appropriate behavior, suggesting it may be a more effective strategy for promoting positive behaviors when reinforcement is delayed.
A translational comparison of contingency-based progressive delay procedures and their effects on contextually appropriate behavior.Iannaccone, JA., Jessel, J.[2021]
Both fixed increment and adjusting interresponse time (IRT) schedules of noncontingent reinforcement (NCR) were effective in reducing self-injurious behavior (SIB) in three individuals diagnosed with mental retardation.
The study demonstrated that both methods maintained their effectiveness in suppressing SIB even as the reinforcement schedules were thinned, indicating their potential utility in behavioral interventions.
A comparison of procedures for programming noncontingent reinforcement schedules.Kahng, SW., Iwata, BA., DeLeon, IG., et al.[2018]
The paper reviews the importance of thinning reinforcement schedules after functional communication training (FCT) to manage excessive communication responses, which can make consistent reinforcement impractical in real-life situations.
It discusses various schedule arrangements and methods for effectively reducing reinforcement while maintaining low levels of problem behavior, highlighting the need for further research on managing the reemergence of such behaviors during this process.
Reinforcement schedule thinning following functional communication training: review and recommendations.Hagopian, LP., Boelter, EW., Jarmolowicz, DP.[2021]

Citations

Resurgence of destructive behavior following differential ...Following Tali's participation, experimenters used the PIA to individualize and systematically inform the schedule of reinforcement in baseline.
Updated Recommendations for Reinforcement Schedule ...After dense-to-lean schedule thinning, problem behavior has an 80% reduction from baseline. ... destructive behavior when thinning reinforcement schedules ...
Resurgence of destructive behavior following differential ...Findings from basic and translational studies have been mixed, and the effects of alternative reinforcement rate on resurgence remain unclear.
Minimizing resurgence of destructive behavior using ...Behavioral momentum theory (BMT) suggests that refinements to FCT could mitigate resurgence of destructive behavior during periods of extinction.
Procedures for determining and then modifying the ...In the progressive-interval assessment, the clinician is able to identify the longest duration of extinction an individual will tolerate before engaging in ...
Evaluating the Use of Competing Items in a Multiple Schedule ...Results showed that the authors successfully maintained a 90% reduction in problem behavior with an average of a 6 min delay to reinforcement.
Systematic Changes in Preference for Schedule-Thinning ...A chained schedule is generally the preferred compound schedule for thinning the schedule of reinforcement for destructive behavior maintained by social- ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security